Plunkett Research Online: La Jolla Pharmaceutical Company

LA JOLLA PHARMACEUTICAL COMPANY (LJPC:NAS) Company Profile, Corporate Revenues, Growth, Market Size, Analysis, Business Forecasts, Market Share, Metrics, SWOT

La Jolla Pharmaceutical Company (LJPC) is a biopharmaceutical firm focused on the research and development of therapeutic products for the treatment of certain life-threatening antibody-mediated diseases, especially autoimmune conditions such as lupus. The firm has several products within its devel.....



La Jolla Pharmaceutical Company
Ticker: LJPC
Exchange: NAS
Parent Company:
Year Established:
Employees:
Fiscal Year Ends in

Phone: 858 207-4264
Fax:
Address: 10182 Telesis Court
6th Floor
San Diego, CA 92122 United States

Types Of Business
Industry Ranks

Industry NAICS code:

Drugs-Autoimmune Diseases
Lupus Treatments
Small-Molecule Therapeutics
ContactsDescription
George TidmarshCEO/Director/President/Secretary
Dennis MulroyCFO/Chief Accounting Officer
See More
La Jolla Pharmaceutical Company (LJPC) is a biopharmaceutical firm focused on the research and development of therapeutic products for the treatment of certain life-threatening antibody-mediated diseases, especially autoimmune conditions such as lupus. The firm has several products within its devel.....See More See More

Auditor: SQUAR MILNER LLP
Legal Advisor: Ropes & Gray LLP
$USD, In whole numbers,
except marked * or %
201620152014201320122011
Financials
    Revenue
    Cost of Revenue
    Gross Margin %
    R&D Expense
    Operating Income
    Operating Margin %
    SGA Expense
    Net Income
    Earnings Per Share
    Dividends
    Book Value Per Share
    Operating Cash Flow
    Capital Expenditure
    Free Cash Flow
Profitability
    EBITDA
    Return on Assets %
    Return on Equity %
    Net Margin %
    Assets Turnover
    Financial Leverage
Brands, Divisions and AffiliatesTop Salaries
LJPC-501
LJPC-401
LJPC-30S
NameTitleSalary (US$)Bonus (US$)
Other ThoughtsCorporate Culture

Apparent Female Officers or Directors: